YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2022Patient reported outcomes (PROs) with 1L durvalumab (D), with or without tremelimumab (T), plus chemotherapy (CT) in metastatic (m) NSCLC: Results from POSEIDONANNALS OF ONCOLOGY
2022Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer MOLECULAR ONCOLOGY
2022Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 studyANNALS OF ONCOLOGY
2022ORCHARD platform study: Osimertinib plus datopotamab deruxtecan (Dato-DXd) cohort in patients (pts) with advanced NSCLC (aNSCLC) who have progressed on first-line (1L) osimertinibANNALS OF ONCOLOGY
2022Optimal Low-Density Lipoprotein Cholesterol Levels in Adults Without Diabetes Mellitus: A Nationwide Population-Based Study Including More Than 4 Million Individuals From South Korea FRONTIERS IN CARDIOVASCULAR MEDICINE
2022Optical coherence tomography in coronary atherosclerosis assessment and intervention NATURE REVIEWS CARDIOLOGY
2022O8-4 KEYNOTE-042: 5-year update of first-line pembrolizumab in Asian patients with locally advanced/metastatic PD-L1-positive NSCLCANNALS OF ONCOLOGY
2022Objective Interpretation of the Rapid Urease Test for Helicobacter pylori Infection Using Colorimetry JOURNAL OF KOREAN MEDICAL SCIENCE
2022Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell CarcinomaNEW ENGLAND JOURNAL OF MEDICINE
2022Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722ANNALS OF ONCOLOGY
2022Next-generation sequencing of molecular tagged circulating cell free DNA of hepatocellular carcinomaCLINICA CHIMICA ACTA
2022Multicenter Prospective Observational Study to Evaluate the Therapeutic Effect and Safety of a Combination of Montelukast and Levocetirizine for Allergic Rhinitis when Administered to Patients with Allergic Rhinitis and AsthmaINTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
2022Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer: Updated HER-RAM study with biomarker analysisJOURNAL OF CLINICAL ONCOLOGY
2022MONARCH 3: Interim overall survival (OS) results of abemaciclib plus a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+, HER2-advanced breast cancer (ABC)ANNALS OF ONCOLOGY
2022MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma-Trial in progressJOURNAL OF CLINICAL ONCOLOGY
2022Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction ESC HEART FAILURE
2022MO4-1 Management of infusion-related reactions in patients receiving amivantamab in the CHRYSALIS studyANNALS OF ONCOLOGY
2022Missed Ipsilateral Adrenal Adenoma With Recurrent Hypercortisolism After Prior Left Adrenalectomy JOURNAL OF KOREAN MEDICAL SCIENCE
2022MARIPOSA-2: Randomized phase III study of amivantamab plus lazertinib plus chemotherapy vs chemotherapy alone in EGFRmutant NSCLC after osimertinib failureANNALS OF ONCOLOGY
2022Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention 3-Year Follow-up of the SMART-CHOICE Randomized Clinical TrialJAMA CARDIOLOGY
1 60 6162636465666768697071 691

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links